Not applicableUnknownNCT00406861What this trial is testingMontelukast in ENL ReactionWho this might be right forErythema Nodosum LeprosumLeprosy The Leprosy Mission Bangladesh 60
Not applicableStudy completedNCT02945176What this trial is testingSafety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis ImplantationWho this might be right forGraft vs Host DiseaseCongenital AniridiaChemical Burns+2 more Implandata Ophthalmic Products GmbH 13
Testing effectiveness (Phase 2)Study completedNCT01275105What this trial is testingA Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)Who this might be right forAllergic Conjunctivitis Eye Therapies, LLC 68
Not applicableUnknownNCT03046914What this trial is testingHLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse ReactionWho this might be right forStevens-Johnson SyndromeKidney Failure, Chronic Seoul National University Hospital 600
Not applicableStudy completedNCT02320214What this trial is testingA Single-Center, Clinical Study to Evaluate the Safety of a Fragranced Personal Lubricant in Healthy Female SubjectsWho this might be right forErythemaEdema Church & Dwight Company, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01045551What this trial is testingOpen Label Pilot Study of Apremilast in Treatment of RosaceaWho this might be right forErythematotelangiectatic RosaceaPapulopustular Rosacea Julian M. Mackay-Wiggan 10
Not applicableNot Yet RecruitingNCT06903429What this trial is testingUsing LUminoMark vs Coventional Practice for Targeted Axillary SurgeryWho this might be right forBreast CancerAxillary Lymph NodesTarget Lesion Kyungpook National University Chilgok Hospital 330
Testing effectiveness (Phase 2)WithdrawnNCT00372723What this trial is testingStudy of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)Who this might be right forToxic Epidermal Necrolysis Loyola University
Testing effectiveness (Phase 2)Active Not RecruitingNCT02411656What this trial is testingPembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior ChemotherapyWho this might be right forEdemaErythemaEstrogen Receptor Negative+6 more M.D. Anderson Cancer Center 71
Not applicableEnded earlyNCT00470392What this trial is testingMechanistically-based Optimization of UV Radiation Therapy in PsoriasisWho this might be right forPsoriasis VA Office of Research and Development 9
Early research (Phase 1)Study completedNCT01301677What this trial is testingUltra Violet B Radiation (UVR) Study of Strontium Chloride Hexahydrate HydrocortisoneWho this might be right forErythemaPain X-pert Med GmbH 47
Not applicableStudy completedNCT02251756What this trial is testingPerformance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.Who this might be right forHealthy Subjects, Male or Female, of 18-60 Years Old, With Phototype I, II or III, Not Pre-treated/Pre-protected Skin Galderma R&D 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662What this trial is testingNew Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.Who this might be right forToxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR) Hospices Civils de Lyon 9
Not applicableUnknownNCT02574988What this trial is testingSevere Cutaneous Adverse Reactions in ThailandWho this might be right forSteven-Johnson SyndromeToxic Epidermal NecrolysisDrug Reaction With Eosinophilia and Systemic Symptoms+2 more Chulalongkorn University 200
Early research (Phase 1)Study completedNCT02039765What this trial is testingPharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.Who this might be right forHyperemia Bausch & Lomb Incorporated 12
Not applicableStudy completedNCT01475708What this trial is testingDoxycycline in Therapy of Erythema MigransWho this might be right forLyme Borreliosis University Medical Centre Ljubljana 400
Not applicableLooking for participantsNCT03462329What this trial is testingPatient's Pretreatment Expectations About Post-Lyme SymptomsWho this might be right forErythema Migrans University Medical Centre Ljubljana 200
Not applicableStudy completedNCT03584919What this trial is testingComparison of Doxycycline and Cefuroxime Axetil in Erythema MigransWho this might be right forErythema Chronicum Migrans University Medical Centre Ljubljana 509
Early research (Phase 1)Study completedNCT06369675What this trial is testingSkin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test DesignWho this might be right forErythema Moberg Pharma AB 45
Not applicableEnded earlyNCT05742347What this trial is testingSkin Protectant Textile Efficacy Study for Managing Skin Fold ConditionsWho this might be right forErythemaMacerationLesion Skin+1 more Medline Industries 47